ARGENX SE is 8.6x more valuable than Apogee Therapeutics, Inc. by market capitalization ($53.35 B vs $6.19 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | APGE | ARGX |
|---|---|---|
| Market cap | $6.19 B | $53.35 B |
| US-listed rank | #1241 | #306 |
| Net income (latest FY) | -$255.84M | - |
| SEC filings | 262 | 272 |
ARGENX SE is 8.6x more valuable than Apogee Therapeutics, Inc. by market capitalization ($53.35 B vs $6.19 B).
Full pages: Apogee Therapeutics, Inc. and ARGENX SE, or browse the full rankings.